Showing 1 - 12 results of 12 for search 'Martijn G. H. van Oijen', query time: 0.05s
Refine Results
-
1
The Use of (Network) Meta-Analysis in Clinical Oncology by Emil ter Veer, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven
Published 2019-08-01
Article -
2
-
3
-
4
Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis by Emil ter Veer, Lok Lam Ngai, Gert van Valkenhoef, Nadia Haj Mohammad, Maarten C. J. Anderegg, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven
Published 2017-08-01
Article -
5
Gastrointestinal symptoms are still prevalent and negatively impact health-related quality of life: a large cross-sectional population based study in The Netherlands. by Merel M Tielemans, Jeroen Jaspers Focks, Leo G M van Rossum, Ties Eikendal, Jan B M J Jansen, Robert J F Laheij, Martijn G H van Oijen
Published 2013-01-01
Article -
6
Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy by Willemieke P.M. Dijksterhuis, Maarten J. Pruijt, Stephanie O. van derWoude, Remy Klaassen, Sophie A. Kurk, Martijn G.H. vanOijen, Hanneke W.M. vanLaarhoven
Published 2019-02-01
Article -
7
Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis by Tom van den Ende, Emil ter Veer, Rosa M. A. Mali, Mark I. van Berge Henegouwen, Maarten C. C. M. Hulshof, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven
Published 2019-04-01
Article -
8
COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis by Tom van den Ende, Frank A. Abe Nijenhuis, Héctor G. van den Boorn, Emil ter Veer, Maarten C. C. M. Hulshof, Suzanne S. Gisbertz, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven
Published 2019-07-01
Article -
9
The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis by Tom van den Ende, Emil ter Veer, Mélanie Machiels, Rosa M. A. Mali, Frank A. Abe Nijenhuis, Laura de Waal, Marety Laarman, Suzanne S. Gisbertz, Maarten C. C. M. Hulshof, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven
Published 2019-01-01
Article -
10
Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric... by Sandor Schokker, Stephanie O. van der Woude, Jessy Joy van Kleef, Daan J. van Zoen, Martijn G. H. van Oijen, Banafsche Mearadji, Ludo F. M. Beenen, Charlotte I. Stroes, Cynthia Waasdorp, R. Aarti Jibodh, Aafke Creemers, Sybren L. Meijer, Gerrit K. J. Hooijer, Cornelis J. A. Punt, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven
Published 2019-06-01
Article -
11
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer by Sanne ten Hoorn, Cynthia Waasdorp, Martijn G. H. van Oijen, Helene Damhofer, Anne Trinh, Lan Zhao, Lisanne J. H. Smits, Sanne Bootsma, Gabi W. van Pelt, Wilma E. Mesker, Linda Mol, Kaitlyn K. H. Goey, Miriam Koopman, Jan Paul Medema, Jurriaan B. Tuynman, Inti Zlobec, Cornelis J. A. Punt, Louis Vermeulen, Maarten F. Bijlsma
Published 2022-04-01
Article -
12
SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer by Héctor G. van den Boorn, Ameen Abu-Hanna, Emil ter Veer, Jessy Joy van Kleef, Florian Lordick, Michael Stahl, Jaffer A. Ajani, Rosine Guimbaud, Se Hoon Park, Susan J. Dutton, Yung-Jue Bang, Narikazu Boku, Nadia Haj Mohammad, Mirjam A.G. Sprangers, Rob H.A. Verhoeven, Aeilko H. Zwinderman, Martijn G.H. van Oijen, Hanneke W.M. van Laarhoven
Published 2019-02-01
Article